Concepedia

Ying Liu

YL

Statistics

Publications

34

Citations

3.9K

H-Index

24

Active since

2011

Affiliations

Qilu Hospital of Shandong University(Current)

Shandong University

Shandong First Medical University

Shandong Tumor Hospital

Second Hospital of Shandong University

Ying Liu is an author at Qilu Hospital of Shandong University specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

2011–2025

34

Publications

34

Acetylation Targets the M2 Isoform of Pyruvate Kinase for Degradation through Chaperone-Mediated Autophagy and Promotes Tumor Growth

Lei Lv, Li Dong, Di Zhao et al. · Molecular Cell · 2011 · 599 citations · Full text

, , +17

circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer

Yuting Sang, Bing Chen, Xiaojin Song et al. · Molecular Therapy · 2019 · 516 citations · Full text

, , +17

RETRACTED ARTICLE: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis

Yiran Liang, Xiaojin Song, Yaming Li et al. · Molecular Cancer · 2020 · 396 citations · Full text

, , +17

LncRNA–CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA‐215

Xiaoli Kong, Yi Duan, Yuting Sang et al. · Journal of Cellular Physiology · 2018 · 301 citations

, , +17

SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1/2

Ning Zhang, Hanwen Zhang, Ying Liu et al. · Cell Death and Differentiation · 2018 · 234 citations · Full text

, , +16

1–5 of 34